S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
Judge rules online archive's book service violated copyright
"Prepare for Five Years of Famine" (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
Judge rules online archive's book service violated copyright
"Prepare for Five Years of Famine" (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
Judge rules online archive's book service violated copyright
"Prepare for Five Years of Famine" (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
Judge rules online archive's book service violated copyright
"Prepare for Five Years of Famine" (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
NASDAQ:PDEX

Pro-Dex - PDEX Stock Forecast, Price & News

$17.00
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.50
▼
$17.11
50-Day Range
$15.29
▼
$17.71
52-Week Range
$12.40
▼
$21.43
Volume
2,817 shs
Average Volume
3,218 shs
Market Capitalization
$60.18 million
P/E Ratio
16.51
Dividend Yield
N/A
Price Target
$30.00

Pro-Dex MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
76.5% Upside
$30.00 Price Target
Short Interest
Healthy
0.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Pro-Dex in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

740th out of 1,005 stocks

Surgical & Medical Instruments Industry

72nd out of 102 stocks

See Top Rated MarketRank™ Stocks Here

PDEX stock logo

About Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

March 22, 2023 | americanbankingnews.com
StockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)
February 27, 2023 | finance.yahoo.com
Pro-Dex's (NASDAQ:PDEX) Returns On Capital Not Reflecting Well On The Business
March 26, 2023 | Investor Place Media (Ad)
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
February 14, 2023 | finance.yahoo.com
Pro-Dex, Inc. Discusses 2nd Quarter Results and 2023 Growth Strategy with The Stock Day Podcast
February 2, 2023 | msn.com
Pro-Dex GAAP EPS of $0.24 misses by $0.05, revenue of $11.28M beats by $0.88M
February 2, 2023 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
January 30, 2023 | seekingalpha.com
Pro-Dex Is Growing But Expensive Given Its Risk
January 20, 2023 | finance.yahoo.com
Why Pro-Dex, Inc. (NASDAQ:PDEX) Could Be Worth Watching
March 26, 2023 | Investor Place Media (Ad)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
January 18, 2023 | reuters.com
PDEX.A - | Stock Price & Latest News | Reuters
December 21, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 19% CAGR over the last five years
November 25, 2022 | msn.com
Pro-Dex Earnings Perspective: Return On Invested Capital
November 23, 2022 | finance.yahoo.com
Declining Stock and Solid Fundamentals: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)?
November 9, 2022 | finance.yahoo.com
Pro-Dex First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
November 4, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results
October 22, 2022 | finance.yahoo.com
Quite a few insiders invested in Pro-Dex, Inc. (NASDAQ:PDEX) last year which is positive news for shareholders
October 17, 2022 | nasdaq.com
Pro-Dex (NASDAQ:PDEX) May Have Issues Allocating Its Capital
September 29, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses Record-Breaking 4th Quarter Results and Year-Over-Year Growth with The Stock Day Podcast
September 26, 2022 | seekingalpha.com
Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
September 20, 2022 | finance.yahoo.com
Some Investors May Be Worried About Pro-Dex's (NASDAQ:PDEX) Returns On Capital
August 25, 2022 | finance.yahoo.com
Pro-Dex, Inc. Announces Fiscal 2022 Fourth Quarter And Full-Year Results
August 6, 2022 | reuters.com
Pro-Dex Inc
July 31, 2022 | nasdaq.com
Here's Why Pro-Dex (NASDAQ:PDEX) Has A Meaningful Debt Burden
July 14, 2022 | finance.yahoo.com
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 21% CAGR over the last five years
June 14, 2022 | finance.yahoo.com
Pro-Dex, Inc. (NASDAQ:PDEX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
June 6, 2022 | finance.yahoo.com
Pro-Dex, Inc. Discusses 2022 Goals and Third Quarter Results with The Stock Day Podcast
May 15, 2022 | finance.yahoo.com
A number of insiders bought Pro-Dex, Inc. (NASDAQ:PDEX) stock last year, which is great news for shareholders
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Company Calendar

Last Earnings
2/02/2023
Today
3/25/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
6/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PDEX
CUSIP
N/A
CIK
788920
Web
www.pro-dex.com
Phone
(949) 769-3200
Fax
949-769-3281
Employees
117
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+76.5%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.03
Trailing P/E Ratio
16.51
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.86 million
Net Margins
8.64%
Pretax Margin
10.38%
Return on Equity
16.12%
Return on Assets
8.19%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
2.69
Quick Ratio
1.39

Sales & Book Value

Annual Sales
$42.04 million
Price / Sales
1.43
Cash Flow
$1.30 per share
Price / Cash Flow
13.05
Book Value
$6.54 per share
Price / Book
2.60

Miscellaneous

Outstanding Shares
3,540,000
Free Float
2,034,000
Market Cap
$60.18 million
Optionable
Not Optionable
Beta
0.99

Key Executives

  • Richard Lee van Kirk
    President, Chief Executive Officer, COO & Director
  • Alisha K. CharltonAlisha K. Charlton
    Chief Financial Officer & Secretary

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













PDEX Stock - Frequently Asked Questions

What is Pro-Dex's stock price forecast for 2023?

0 Wall Street research analysts have issued 12 month price targets for Pro-Dex's stock. Their PDEX share price forecasts range from $30.00 to $30.00. On average, they anticipate the company's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 76.5% from the stock's current price.
View analysts price targets for PDEX or view top-rated stocks among Wall Street analysts.

How have PDEX shares performed in 2023?

Pro-Dex's stock was trading at $15.90 at the start of the year. Since then, PDEX stock has increased by 6.9% and is now trading at $17.00.
View the best growth stocks for 2023 here.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our PDEX earnings forecast.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) posted its earnings results on Thursday, February, 2nd. The medical instruments supplier reported $0.24 EPS for the quarter. The medical instruments supplier had revenue of $11.28 million for the quarter. Pro-Dex had a net margin of 8.64% and a trailing twelve-month return on equity of 16.12%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (1.66%) and Advisor Group Holdings Inc. (0.47%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends.

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $17.00.

How much money does Pro-Dex make?

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $60.18 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.03 on an earnings per share basis.

How many employees does Pro-Dex have?

The company employs 117 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.

This page (NASDAQ:PDEX) was last updated on 3/26/2023 by MarketBeat.com Staff